40 results match your criteria: "Hospital Universitario Virgen Arrixaca[Affiliation]"

Article Synopsis
  • The study investigates gender disparities in access to liver transplantation in Spain, focusing on the performance of the Gender-Equity Model adjusted by serum sodium (GEMA-Na) compared to the traditional Model for End-stage Liver Disease 3.0 (MELD 3.0).
  • It includes a nationwide cohort of 6,071 patients and finds that women have lower access to transplantation and a higher risk of mortality or delisting within the first 90 days.
  • GEMA-Na shows better predictive accuracy for waiting list outcomes than MELD 3.0, suggesting it could be the preferred method for prioritizing patients on the liver transplant waiting list.
View Article and Find Full Text PDF

Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy.

JACC Clin Electrophysiol

June 2024

Department of Cardiology, Virgen de las Nieves University Hospital, Granada, Spain; Instituto de Investigación Biosanitaria. ibs.GRANADA, Granada, Spain. Electronic address:

Background: Desmin (DES) pathogenic variants cause a small proportion of arrhythmogenic cardiomyopathy (ACM). Outcomes data on DES-related ACM are scarce.

Objectives: This study sought to provide information on the clinical phenotype and outcomes of patients with ACM caused by pathogenic variants of the DES gene in a multicenter cohort.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate if dementia predicts mortality independently after older adults visit emergency departments during the first wave of COVID-19.
  • Data was collected from nearly 10,000 patients aged 65 and older, with 15.5% having a prior history of dementia and 31.3% diagnosed with COVID-19.
  • The findings revealed that dementia significantly increased the risk of death at 30, 180, and 365 days, particularly among those with a COVID-19 diagnosis.
View Article and Find Full Text PDF
Article Synopsis
  • The study estimates pneumonia incidence in elderly patients in Spanish emergency departments, finding an annual rate of 18.4 cases per 1000 inhabitants.
  • A significant 78% of these patients required hospitalization, with 30-day mortality at 14.2% and in-hospital mortality at 12.9%.
  • Factors like functional dependency and severe comorbidity were closely linked to adverse events, while common biomarkers showed only moderate predictive ability for outcomes.
View Article and Find Full Text PDF

Background: Polypharmacy is a growing phenomenon among elderly individuals. However, there is little information about the frequency of polypharmacy among the elderly population treated in emergency departments (EDs) and its prognostic effect. This study aims to determine the prevalence and short-term prognostic effect of polypharmacy in elderly patients treated in EDs.

View Article and Find Full Text PDF

Introduction: Mortality in emergency departments (EDs) is not well known. This study aimed to assess the impact of the first-wave pandemic on deaths accounted in the ED of older patients with COVID and non-COVID diseases.

Methods: We used data from the Emergency Department and Elderly Needs (EDEN) cohort (pre-COVID period) and from the EDEN-COVID cohort (COVID period) that included all patients ≥65 years seen in 52 Spanish EDs from April 1 to 7, 2019, and March 30 to April 5, 2020, respectively.

View Article and Find Full Text PDF

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial.

J Clin Oncol

October 2023

Department of Gynecology with Center for Oncological Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.

Purpose: Platinum-based doublets with concurrent and maintenance bevacizumab are standard therapy for ovarian cancer (OC) relapsing after a platinum-free interval (PFI) >6 months. Immunotherapy may be synergistic with bevacizumab and chemotherapy.

Patients And Methods: ATALANTE/ENGOT-ov29 (ClinicalTrials.

View Article and Find Full Text PDF

Risks of Ventricular Arrhythmia and Heart Failure in Carriers of Variants.

Circ Genom Precis Med

October 2023

Institute of Cardiovascular Science, University College London, United Kingdom (D.E.C., A.P., A.B., P.S., M.L., P.M.E.).

Background: Variants in are reported in 2% to 6% of familial cases of dilated cardiomyopathy and may be associated with fatal ventricular arrhythmia and rapid heart failure progression. We sought to determine the risk of adverse events in variant carriers and the impact of sex on outcomes.

Methods: Consecutive probands and relatives carrying variants were retrospectively recruited from 12 cardiomyopathy units.

View Article and Find Full Text PDF
Article Synopsis
  • Calmodulinopathy is caused by mutations in CALM genes and leads to serious arrhythmias, particularly in young people; the ICalmR aims to connect clinical symptoms with molecular causes.
  • The ICalmR has gathered data from 140 patients, showing a notable presence of CALM-LQTS and CALM-CPVT, and has observed a decrease in the frequency of serious cardiac events compared to past data.
  • The condition presents a wide range of symptoms, from severe arrhythmias to no symptoms at all; while therapy options are limited and based on current practices, management often involves medication and devices like defibrillators.
View Article and Find Full Text PDF

Objectives: To study baseline factors associated with hypo- and hypernatremia in older patients attended in emergency departments (EDs) and explore the association between these dysnatremias and indicators of severity in an emergency.

Material And Methods: We included patients attended in 52 Spanish hospital EDs aged 65 years or older during a designated week. All included patients had to have a plasma sodium concentration on record.

View Article and Find Full Text PDF

Objective: To investigate the relationship between the age of an urgently hospitalized patient and his or her probability of admission to an intensive care unit (ICU).

Design: Observational, retrospective, multicenter study.

Setting: 42 Emergency Departments from Spain.

View Article and Find Full Text PDF

The better understanding of the safety of biologic DMARDs (bDMARDs), as well as the emergence of new bDMARDs against different therapeutic targets and biosimilars have likely influenced the use patterns of these compounds over time. The aim of this study is to assess changes in demographic characteristics, disease activity and treatment patterns in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), or ankylosing spondylitis (AS) who started a first- or second-line biologic between 2007 and mid-2020. Patients diagnosed with RA, PsA or AS included in the BIOBADASER registry from January 2007 to July 2020 were included.

View Article and Find Full Text PDF

Importance: Truncating variants in the gene encoding filamin C (FLNCtv) are associated with arrhythmogenic and dilated cardiomyopathies with a reportedly high risk of ventricular arrhythmia.

Objective: To determine the frequency of and risk factors associated with adverse events among FLNCtv carriers compared with individuals carrying TTN truncating variants (TTNtv).

Design, Setting, And Participants: This cohort study recruited 167 consecutive FLNCtv carriers and a control cohort of 244 patients with TTNtv matched for left ventricular ejection fraction (LVEF) from 19 European cardiomyopathy referral units between 1990 and 2018.

View Article and Find Full Text PDF

Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the Gene.

Circ Heart Fail

October 2020

Department of Inherited Cardiovascular Diseases, Bart's Heart Centre, St. Bartholomew's Hospital, London, United Kingdom (M.M.A., M.L., L.R.L., P.M.E.).

Background: Truncating variants in the gene (TTNtv) are the commonest cause of heritable dilated cardiomyopathy. This study aimed to study the phenotypes and outcomes of TTNtv carriers.

Methods: Five hundred thirty-seven individuals (61% men; 317 probands) with TTNtv were recruited in 14 centers (372 [69%] with baseline left ventricular systolic dysfunction [LVSD]).

View Article and Find Full Text PDF

The clinical diagnosis of von Willebrand disease (VWD), particularly type 1, can be complex because several genetic and environmental factors affect von Willebrand factor (VWF) plasma levels. An estimated 60% of the phenotypic variation is attributable to hereditary factors, with the ABO blood group locus being the most influential. However, recent studies provide strong evidence that nonsynonymous single nucleotide variants (SNVs) contribute to VWF and factor VIII phenotypic variability in healthy individuals.

View Article and Find Full Text PDF

Large studies in von Willebrand disease patients, including Spanish and Portuguese registries, led to the identification of >250 different mutations. It is a challenge to determine the pathogenic effect of potential splice site mutations on mRNA. This study aimed to elucidate the true effects of 18 mutations on mRNA processing, investigate the contribution of next-generation sequencing to mRNA study in von Willebrand disease, and compare the findings with prediction.

View Article and Find Full Text PDF

The multimeric analysis (MA) of plasma von Willebrand factor (VWF) evaluates structural integrity and helps in the diagnosis of von Willebrand disease (VWD). This assay is a matter of controversy, being considered by some investigators cumbersome and only slightly informative. The centralised study 'Molecular and Clinical Profile of von Willebrand Disease in Spain (PCM-EVW-ES)' has been carried out by including the phenotypic assessment and the genetic analysis by next generation sequencing (NGS) of the VWF gene (VWF).

View Article and Find Full Text PDF

Testicular germ cell tumors (TGCTs) are a clinically and pathologically heterogeneous disease, and little is known of its genetic basis. Only low susceptibility risk loci have been identified for both sporadic and familial cases. Therefore, we tried to identify new susceptibility genes responsible for familial testicular cancer that may contribute to increasing our knowledge about the genetic basis of the disease.

View Article and Find Full Text PDF

Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study.

Clin Immunol

October 2014

Farmacología y Toxicología, Centro de Diagnóstico Biomédico, IDIBAPS, Hospital Clínico, Universidad de Barcelona, c/Villarroel 170, 08036 Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), c/Sinesio Delgado 4, 28029 Madrid, Spain. Electronic address:

Article Synopsis
  • Acute rejection (AR) is a significant challenge in organ transplantation, prompting the search for predictive biomarkers in liver and kidney transplant recipients.
  • A multicenter study analyzed various biomarkers, including IFN-γ, IL-17, and IL-2, both before and after transplantation, involving 142 patients (63 liver, 79 kidney), where 28 developed AR.
  • The study found that specific intracellular expressions of these biomarkers could predict a high risk of AR, leading to the development of risk prediction models that can inform future treatment strategies and help tailor immunosuppressive therapies.
View Article and Find Full Text PDF

High proportion of pretransplantation activated regulatory T cells (CD4+CD25highCD62L+CD45RO+) predicts acute rejection in kidney transplantation: results of a multicenter study.

Transplantation

December 2014

1 Servicio de Inmunología, Hospital Universitario Marqués de Valdecilla-IFIMAV, Santander, Spain. 2 Farmacología y Toxicología, Centro de Diagnóstico Biomédico, IDIBAPS, Hospital Clínico, Universidad de Barcelona, Barcelona, Spain. 3 Servicio de Epidemiología, Gerencia de Atención Primaria-IFIMAV, Santander, Spain. 4 Servicio de Inmunología, Hospital Universitario Virgen Arrixaca, Murcia, Spain. 5 Instituto de Investigación del Hospital 12 de Octubre, Servicio de Inmunología Hospital 12 de Octubre, Facultad de Medicina Universidad Complutense de Madrid, Universidad CEU San Pablo, Madrid, Spain. 6 Instituto de Investigación del Hospital 12 de Octubre, Servicio de Inmunología Hospital 12 de Octubre, Madrid, Spain. 7 Instituto de Investigación del Hospital 12 de Octubre, Servicio de Nefrología Hospital 12 de Octubre, Facultad de Medicina Universidad Complutense de Madrid, Madrid, Spain. 8 Farmacología Clínica, Hospital Universitario Marqués de Valdecilla-IFIMAV, Santander, Spain. 9 Unidad de Trasplante Renal, Servicio de Nefrologia, Fundació Puigvert, Barcelona, Spain. 10 Servicio de Nefrologia, Hospital Universitario Virgen Arrixaca, Murcia, Spain. 11 Servicio de Nefrología, Hospital del Mar, Barcelona, Spain. 12 Servicio de Nefrología, Hospital Universitario Marqués de Valdecilla-IFIMAV, Santander, Spain. 13 Address correspondence to: Marcos López-Hoyos, M.D., Ph.D., Servicio de Inmunología. Hospital Universitario Marqués de Valdecilla. Avenida Valdecilla s/n. CP 39008. Santander, Cantabria, Spain.

Background: Prognostic biomarkers of acute rejection (AR) in solid organ transplantation have been addressed in multiple small retrospective studies, and there is a critical need for multicenter studies. Because of their tolerogenic properties, regulatory T cells (Tregs) play an important role in transplant outcome.

Methods: In the present multicenter study, we have retrospectively examined different Treg subpopulations in an independent cohort of kidney transplant patients within first year after kidney transplantation.

View Article and Find Full Text PDF

The role of radiosurgery after multimodality treatment of recurrent desmoplastic adult medulloblastoma is analyzed. The ultra-early clinical and pathological response of this tumor to adjunctive radiosurgery is stressed.

View Article and Find Full Text PDF